HIA
REGN icon

Harbor Investment Advisory’s Regeneron Pharmaceuticals REGN Stock Holding History

Harbor Investment Advisory’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.49M Sell
2,382
-100
-4% -$68.1K 0.1% 152
2026
Q1 		$1.92M Sell
2,482
-17
-0.7% -$13K 0.15% 114
2025
Q4 		$1.93M Sell
2,499
-149
-6% -$101K 0.14% 111
2025
Q3 		$1.49M Sell
2,648
-27
-1% -$15.3K 0.12% 134
2025
Q2 		$1.4M Sell
2,675
-523
-16% -$292K 0.13% 133
2025
Q1 		$2.03M Sell
3,198
-414
-11% -$285K 0.2% 91
2024
Q4 		$2.57M Sell
3,612
-52
-1% -$43.6K 0.24% 78
2024
Q3 		$3.85M Sell
3,664
-100
-3% -$111K 0.38% 52
2024
Q2 		$3.96M Buy
3,764
+56
+2% +$54.3K 0.41% 44
2024
Q1 		$3.57M Buy
3,708
+35
+1% +$33.3K 0.37% 53
2023
Q4 		$3.23M Buy
3,673
+50
+1% +$41.2K 0.37% 54
2023
Q3 		$2.98M Sell
3,623
-5
-0.1% -$3.93K 0.39% 51
2023
Q2 		$2.61M Hold
3,628
– – 0.36% 60
2023
Q1 		$2.98M Sell
3,628
-400
-10% -$302K 0.45% 51
2022
Q4 		$2.91M Sell
4,028
-50
-1% -$36.9K 0.45% 54
2022
Q3 		$2.81M Sell
4,078
-313
-7% -$197K 0.46% 47
2022
Q2 		$2.6M Sell
4,391
-344
-7% -$224K 0.42% 52
2022
Q1 		$3.31M Buy
4,735
+112
+2% +$70.9K 0.44% 48
2021
Q4 		$2.92M Sell
4,623
-266
-5% -$164K 0.37% 53
2021
Q3 		$2.96M Buy
4,889
+145
+3% +$90K 0.4% 51
2021
Q2 		$2.65M Buy
4,744
+516
+12% +$261K 0.36% 59
2021
Q1 		$2M Buy
4,228
+460
+12% +$224K 0.3% 70
2020
Q4 		$1.82M Buy
3,768
+2,823
+299% +$1.52M 0.29% 71
2020
Q3 		$529K Buy
945
+119
+14% +$72.2K 0.1% 161
2020
Q2 		$515K Buy
826
+24
+3% +$13.6K 0.11% 151
2020
Q1 		$392K Buy
802
+87
+12% +$35.9K 0.11% 153
2019
Q4 		$268K Buy
+715
New +$241K 0.06% 218

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Harbor Investment Advisory's REGN Position: Q2 2026 in Review

Harbor Investment Advisory reduced its Regeneron Pharmaceuticals (REGN) stake by 4% in Q2 2026, selling an estimated $68.1K and leaving 2,382 shares worth $1.49M. The position accounts for 0.1% of the portfolio, ranked #152.

Harbor Investment Advisory first reported a position in REGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.96M in Q2 2024. 336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Harbor Investment Advisory held 2,382 shares of Regeneron Pharmaceuticals worth $1.49M as of Q2 2026.
  • Harbor Investment Advisory sold 100 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $68.1K.
  • Regeneron Pharmaceuticals made up 0.1% of Harbor Investment Advisory's portfolio in Q2 2026, its #152 holding.
  • Harbor Investment Advisory first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • Harbor Investment Advisory's Regeneron Pharmaceuticals position peaked at $3.96M in Q2 2024.
  • 336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.